Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 3 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Alx Oncology Holdings Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 3 filings
- 2 insiders, $8.27K in total
- Insiders trading
- 2
- Net value
- −$8.27K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Alx Oncology Holdings Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Lettmann Jason | CHIEF EXECUTIVE OFFICER | 294,379 | Aug 18, 2026 | 5 |
| Pinto Shelly | SVP, FINANCE AND CAO | 87,828 | Aug 18, 2026 | 7 |
| Klencke Barbara | Chief Medical Officer | – | Apr 17, 2026 | 2 |
| Knight Jeff E. | Chief Dev & Operating Officer | – | Apr 17, 2026 | 1 |
| Goodman Corey S | Director, 10% Owner | 8,453,038Indirect | Feb 4, 2026 | 2 |
| Shantharam Harish | Chief Financial Officer | 75,000 | Jan 28, 2026 | 2 |
| Garland J. Scott | Director | – | Jan 21, 2026 | 1 |
| Takimoto Chris H | Director | – | Jan 21, 2026 | 1 |
| Hemrajani Rekha | Director | 33,000 | Jan 21, 2026 | 1 |
| Sandler Alan B. | Director | – | Jan 21, 2026 | 1 |
| Curran Daniel J. | Director | – | Jan 21, 2026 | 1 |
| Pons Jaume | PRESIDENT & CSO | 579,388 | Feb 21, 2025 | 0 |
| Garcia Peter S | CHIEF FINANCIAL OFFICER | 121,516 | Aug 16, 2024 | 0 |
| Randolph Sophia | CHIEF MEDICAL OFFICER | 325,711 | Aug 16, 2024 | 0 |
| Nielsen Jack | Director, 10% Owner | – | Jun 22, 2023 | 0 |
| Canamasas Itziar | Director | – | Jun 22, 2023 | 0 |
| George Jean | 10% Owner | 285,956Indirect | Dec 15, 2021 | 0 |
| Carusi Michael A | 10% Owner | 285,956Indirect | Dec 15, 2021 | 0 |
| Plain Henry A JR | 10% Owner | 285,956Indirect | Dec 15, 2021 | 0 |
| Lightstone Ventures, L.P. | 10% Owner | 285,956Indirect | Dec 15, 2021 | 0 |
| Lightstone Ventures (A), L.P. | 10% Owner | 285,956Indirect | Dec 15, 2021 | 0 |
| LSV Associates, LLC | 10% Owner | 285,956Indirect | Dec 15, 2021 | 0 |
| Lightstone Ventures II, L.P. | 10% Owner | 285,956Indirect | Dec 15, 2021 | 0 |
| Lightstone Ventures II (A), L.P. | 10% Owner | 285,956Indirect | Dec 15, 2021 | 0 |
| LSV Associates II, LLC | 10% Owner | 285,956Indirect | Dec 15, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 (view filing)9:48 PM ET | Dec 13 | 2 days | Lettmann JasonDirector, 10% Owner | SSale | −325.4K | $27.36 | −$8.90M | −53.2%286.0K after | 12 lots |
| Dec 15, 2021 (view filing)9:03 PM ET | Dec 13 | 2 days | George Jean and 8 others10% Owner | SSale | −48.4K | $26.61 | −$1.29M | −14.5%286.0K after | 12 lots |
| Dec 10, 2021 (view filing)7:51 PM ET | Dec 8-10 | 2 days | George Jean and 8 others10% Owner | SSale | −145.6K | $32.26 | −$4.70M | −33.3%291.8K after | 16 lotsDuplicate filing |
| Dec 10, 2021 (view filing) | Dec 8-10 | 2 days | Lettmann JasonDirector, 10% Owner | SSale | −145.6K | $32.26 | −$4.70M | −33.3%291.8K after | 16 lots |
| Nov 23, 2021 (view filing) | Nov 22 | 1 day | Randolph SophiaChief Medical Officer | SSale | −14.9K | $36.77 | −$547.3K | −8.3%164.5K after | |
| Oct 20, 2021 (view filing) | Oct 19 | 1 day | Pons JaumePresident & CEO | SSale | −16.7K | $54.30 | −$906.8K | −3.6%444.6K after | 2 lotsDuplicate filing |
| Oct 20, 2021 (view filing) | Oct 19 | 1 day | Pons JaumePresident & CEO | SSale | −16.7K | $54.30 | −$906.8K | −3.6%444.6K after | 2 lots |
| Oct 19, 2021 (view filing) | Oct 18 | 1 day | Garcia Peter SChief Financial Officer | SSale | −7.23K | $55.44 | −$400.8K | −43.7%9.33K after | 6 lots |
| Oct 12, 2021 (view filing) | Oct 11 | 1 day | Randolph SophiaChief Medical Officer | SSale | −7.39K | $60.98 | −$450.4K | −4.7%149.4K after | 2 lots |
| Sep 21, 2021 (view filing) | Sep 20 | 1 day | Pons JaumePresident & CEO | SSale | −16.7K | $74.39 | −$1.24M | −3.5%461.3K after | 4 lots |
| Sep 17, 2021 (view filing) | Sep 16-17 | 1 day | Garcia Peter SChief Financial Officer | SSale | −12.8K | $79.12 | −$1.01M | −57.8%9.33K after | 6 lots |
| Sep 13, 2021 (view filing) | Sep 10 | 3 days | Randolph SophiaChief Medical Officer | SSale | −7.39K | $77.66 | −$573.7K | −4.5%156.8K after | 3 lots |
| Aug 24, 2021 (view filing) | Aug 23 | 1 day | Garcia Peter SChief Financial Officer | SSale | −60.0K | $74.15 | −$4.45M | −86.5%9.33K after | 8 lots |
| Aug 20, 2021 (view filing) | Aug 19 | 1 day | Pons JaumePresident & CEO | SSale | −16.7K | $61.28 | −$1.02M | −3.4%478.0K after | 7 lots |
| Aug 18, 2021 (view filing) | Aug 17 | 1 day | Garcia Peter SChief Financial Officer | SSale | −10.0K | $66.23 | −$662.3K | −51.7%9.33K after | 5 lots |
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Randolph SophiaChief Medical Officer | SSale | −7.39K | $64.64 | −$477.5K | −4.3%164.2K after | 3 lots |
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Pons JaumePresident & CEO | SSale | −16.7K | $54.56 | −$911.2K | −3.3%494.5K after | 3 lots |
| Jul 14, 2021 (view filing) | Jul 12 | 2 days | Randolph SophiaChief Medical Officer | SSale | −7.39K | $54.90 | −$405.6K | −4.1%171.6K after | 2 lots |